| Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy (NCT00174187) | Pfizer | 2000-09-01 |
| Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia (NCT00038311) | Pfizer | 2000-09-01 |
| Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease (NCT00036205) | Pfizer | 2000-08-01 |
| Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia (NCT00039910) | Pfizer | 2000-07-01 |
| Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients (NCT00240747) | Pfizer | 2000-06-01 |
| A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation (NCT00150241) | Pfizer | 2000-02-01 |
| Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia (NCT00037791) | Pfizer | 1999-12-01 |
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT00005093) | Pfizer | 1999-12-01 |
| Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults (NCT00527046) | Pfizer | 1999-12-01 |
| Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer (NCT00004252) | Pfizer | 1999-11-01 |
| To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. (NCT00141336) | Pfizer | 1999-11-01 |
| Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00004200) | Pfizer | 1999-10-01 |
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer (NCT00004861) | Pfizer | 1999-10-01 |
| Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy. (NCT00141401) | Pfizer | 1999-09-01 |
| Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes (NCT00424411) | Pfizer | 1999-09-01 |
| Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus. (NCT00424437) | Pfizer | 1999-09-01 |
| Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer (NCT00004071) | Pfizer | 1999-08-01 |
| Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease (NCT00467766) | Pfizer | 1999-07-01 |
| Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy. (NCT00370565) | Pfizer | 1999-06-01 |
| Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes (NCT00424333) | Pfizer | 1999-05-01 |
| This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque. (NCT00380939) | Pfizer | 1999-04-01 |
| Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer (NCT00004199) | Pfizer | 1999-03-01 |
| Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD (NCT00159835) | Pfizer | 1999-02-01 |
| Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer (NCT01061359) | Pfizer | 1999-01-01 |
| Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse (NCT00003775) | Pfizer | 1998-12-01 |
| Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke (NCT00147602) | Pfizer | 1998-11-01 |
| To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. (NCT00141245) | Pfizer | 1998-10-01 |
| A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. (NCT00163111) | Pfizer | 1998-09-01 |
| SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma (NCT00003720) | Pfizer | 1998-07-01 |
| To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures (NCT00141388) | Pfizer | 1998-07-01 |
| Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years (NCT00161746) | Pfizer | 1998-04-01 |
| A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels (NCT00327691) | Pfizer | 1998-04-01 |
| Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception (NCT00139685) | Pfizer | 1998-04-01 |
| Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer (NCT00003343) | Pfizer | 1998-03-01 |
| CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse (NCT00003673) | Pfizer | 1998-03-01 |
| SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme (NCT00003293) | Pfizer | 1998-02-01 |
| Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer (NCT00038467) | Pfizer | 1998-02-01 |
| To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy. (NCT00141414) | Pfizer | 1997-11-01 |
| CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse (NCT00003131) | Pfizer | 1997-02-01 |
| Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary (NCT00174278) | Pfizer | 1997-02-01 |
| CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events (NCT00327418) | Pfizer | 1997-01-01 |
| Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation (NCT01073605) | Pfizer | 1993-07-01 |
| A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT00751127) | Pfizer | 1993-01-01 |
| Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age (NCT00174408) | Pfizer | 1990-03-01 |
| A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS (NCT00002282) | Pfizer | |
| Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS (NCT00001017) | Pfizer | |
| Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis (NCT00002075) | Pfizer | |
| A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak (NCT00506610) | Pfizer | |
| An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine (NCT03934086) | Pfizer | |
| A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis (NCT00002305) | Pfizer | |
| Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) (NCT00034957) | Pfizer | |
| Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs (NCT00002328) | Pfizer | |
| An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy (NCT00002089) | Pfizer | |
| Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600) (NCT05522556) | Pfizer | |
| CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery (NCT00635245) | Pfizer | |
| A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common (NCT00002325) | Pfizer | |
| Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation (NCT00435747) | Pfizer | |
| A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients (NCT00002309) | Pfizer | |
| Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options (NCT03943615) | Pfizer | |
| Inotuzumab Ozogamicin - PF-05208773 (NCT03127605) | Pfizer | |
| Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options (NCT04724421) | Pfizer | |
| A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS (NCT00002294) | Pfizer | |
| A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis (NCT00002068) | Pfizer | |
| A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients (NCT00002140) | Pfizer | |
| Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome (NCT00002074) | Pfizer | |
| A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients (NCT00002122) | Pfizer | |
| Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects. (NCT00002139) | Pfizer | |
| Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy (NCT00002038) | Pfizer | |
| Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135) (NCT05238311) | Pfizer | |
| Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis (NCT00002040) | Pfizer | |
| Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma (NCT00036140) | Pfizer | |
| A Study of Azithromycin in HIV-Infected Patients (NCT00002344) | Pfizer | |
| A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems (NCT00002304) | Pfizer | |
| A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections (NCT00002277) | Pfizer | |
| Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (NCT04564755) | Pfizer | |
| Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis (NCT00002076) | Pfizer | |
| A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B (NCT00002306) | Pfizer | |
| Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction (NCT00037804) | Pfizer | |
| A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS (NCT00000966) | Pfizer | |
| An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) (NCT00002090) | Pfizer | |
| Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate (NCT02142868) | Pfizer | |
| An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis (NCT00002077) | Pfizer | |
| Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC (NCT02824094) | Pfizer | |
| Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease (NCT00962260) | Pfizer | |
| Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis (NCT00002010) | Pfizer | |
| A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems (NCT00002339) | Pfizer | |
| Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive (NCT03178071) | Pfizer | |
| Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study (NCT00002082) | Pfizer | |
| Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076) (NCT05650476) | Pfizer | |
| Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome (NCT00002112) | Pfizer | |
| A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis. (NCT00002113) | Pfizer | |
| Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients (NCT02473497) | Pfizer | |
| A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy (NCT00002085) | Pfizer | |
| Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842) (NCT05466578) | Pfizer | |
| Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients. (NCT06025227) | Pfizer | |
| Lorlatinib - PF-06463922 (NCT03127618) | Pfizer | |
| Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy (NCT02312037) | Pfizer | |
| Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma (NCT05462639) | Pfizer | |